* When endo


When endovascular A we we


unique solutions for cl We are proud to


cular AV fistula cr


we were there with the innovative WavelinQ™ EndoAVF System. As a leader iader i the ES


there with the i n the ESKD medidical dev er these tra support for you


ue solutions for clinicians and patients for more than 40 years. We are proud to offer these transformative technologies and comprehensive support for your ESKD practice.


cal device industry, BD has been developing ians a


la c eation entered the US market in 2018, at


*In the US,calculated based on dollar sales. IQVIA Data total based on a hospital sample from Q1 2019 through Q2 2020 market share data.


The WavelinQ™ EndoAVF System is indicated for the creation of an arteriovenous fistula (AVF) using concomitant ulnar artery and ulnar vein or concomitant radial artery and radial vein in patients with minimum artery and vein diameters of 2.0 mm at the fistula creation site who have chronic kidney disease and need hemodialysis.


bd.com/wavelinq BD, Tempe, AZ, USA, 1 800 321 4254


Please consult package insert for more detailed safety information and instructions for use. BD, the BD Logo, and WavelinQ are trademarks of Becton, Dickinson and Company or an affiliate. © 2021 BD. Illustrations by Mike Austin. © 2021. All rights reserved. BD-22611


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40